XIONG Ting-ting, ZHOU Jian-hua, ZHU Dan-dan, et al. Effects of MicroRNA-520b Associated with Blood Stasis Syndrome on Interleukin-8 and Intervention of Tanshinone Ⅱ[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 113-117.
XIONG Ting-ting, ZHOU Jian-hua, ZHU Dan-dan, et al. Effects of MicroRNA-520b Associated with Blood Stasis Syndrome on Interleukin-8 and Intervention of Tanshinone Ⅱ[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 113-117. DOI: 10.13422/j.cnki.syfjx.2015100113.
Objective: To investigate the effects of microRNA-520b(miR-520b) associated with blood stasis syndrome on interleukin-8(IL-8) and the intervention of tanshinone ⅡA(Tan ⅡA). Method: Synthetic miR-520b mimic(50 nmol · L-1) or inhibitor (100 nmol · L-1) were transfected into 1.6×104 cells/well human umbilical venous endothelial cells (HUVECs) 24
36
48 h by lipofectamineTM 2000 and then
5
10
20
40 mg ·L-1 Tan ⅡA intervented miR520b-transfected HUVECs 24
48 h. The proliferation(n=5) and nitric oxide(NO)
endothelial protein C receptor(EPCR)
Von Willebrand factor(vWF)
thrombomodulin(TM) and endothelin(ET)' s concentration of HUVECs were analyzed by MTT assay
nitrate reduction assay and ELISA assay respectively(n=3). Transfection efficiency of miR-520b was detected by the fluorescence microscope and IL-8 mRNA and protein were also detected(n=3). Result: Compared with normal group
miR-520b inhibited the proliferation and NO concentration
and promoted the EPCR
vWF
and ET concentration of HUVECs in the miR-520b group. After 48 hours
the expression of IL-8 mRNA and protein were significantly decreased in miR-520b group. Tan ⅡA increased significantly the proliferation and NO concentration
and decreased significantly the EPCR
vWF
TM and ET concentration of HUVECs. Additionally
the expression of IL-8 mRNA and protein were significantly increased in the Tan ⅡA group
in comparison to the miR-520b group. Conclusion: MicroRNA-520b may promote the development of blood stasis syndrome in HUVECs by inhibiting the expression of IL-8. This process may be reversed by Tan ⅡA.